Trial ID or NCT#
NCT03003299
Status
NOT RECRUITING
Purpose
To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.
Investigator(s)
D. Craig Miller, MD
Alan C. Yeung, MD
Michael Fischbein, MD
William Fearon, MD
David Liang, MD
Rajesh Dash, MD
Anson Lee, MD
Contact us to find out if this trial is right for you.
CONTACT
Leigh Trautman, RN
(650) 725-3931
View on ClinicalTrials.gov